| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 7 3313-3321, Copyright © 1995 by American Association of Immunologists
ARTICLES |
W Bohm, R Schirmbeck, A Elbe, K Melber, D Diminky, G Kraal, N van Rooijen, Y Barenholz and J Reimann
Institute for Medical Microbiology, University of Ulm, Germany.
Injection of low doses of particulate hepatitis B surface Ag (HBsAg) into H-2d mice without adjuvants primes an Ld-restricted, S28-39- specific T cell response. This study indicates that dendritic cells (DC) and macrophages (M phi) both serve as APCs that support priming of CD8+ CTL precursors in vivo to exogenous HBsAg particles. After transfer into a syngeneic, naive host, HBsAg particle-pulsed DC, either freshly purified from skin or derived from a cloned DC line, efficiently primed class I-restricted, HBsAg-specific CTL precursors. M phi, either harvested from the peritoneal cavity or generated in macrophage-CSF-stimulated bone marrow cell cultures in vitro or derived from established, cloned M phi lines (PU5-1.8, J774A.1), pulsed with HBsAg particles in vivo or in vitro, elicited a class I-restricted, HBsAg-specific CTL response after adoptive transfer into naive hosts. The class I-restricted CTL response induced by HBsAg particle immunization was suppressed in carrageenan-treated mice, but was restored when carrageenan-treated mice were immunized with syngeneic, HBsAg-pulsed M phi. Selective elimination of M phi by liposome- incorporated dichloromethylene-diphosphonat did not suppress the induction of a CTL response of H-2d mice by HBsAg particle immunization. HBsAg-pulsed, freshly prepared DC are more potent than pulsed M phi in priming class I-restricted CTL in vivo. The relative importance of both types of APC in priming CTL remains to be resolved.
This article has been cited by other articles:
|
|
 |
|
  E. Guzman, G. Taylor, B. Charleston, M. A. Skinner, and S. A. Ellis An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV J. Gen. Virol., March 1, 2008; 89(3): 667 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Elmowalid, M. Qiao, S.-H. Jeong, B. B. Borg, T. F. Baumert, R. K. Sapp, Z. Hu, K. Murthy, and T. J. Liang Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees PNAS, May 15, 2007; 104(20): 8427 - 8432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. J. Wong and R. F. Siliciano Contribution of Virus-Like Particles to the Immunogenicity of Human Immunodeficiency Virus Type 1 Gag-Derived Vaccines in Mice J. Virol., February 1, 2005; 79(3): 1701 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Yao, R. Zhang, L. Guo, M. Li, and C. Chen Th Cell-Independent Immune Responses to Chimeric Hemagglutinin/Simian Human Immunodeficiency Virus-Like Particles Vaccine J. Immunol., August 1, 2004; 173(3): 1951 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Moron, P. Rueda, C. Sedlik, and C. Leclerc In Vivo, Dendritic Cells Can Cross-Present Virus-Like Particles Using an Endosome-to-Cytosol Pathway J. Immunol., September 1, 2003; 171(5): 2242 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. SOSROSENO and E. HERMINAJENG The role of macrophages in the induction of murine immune response to Actinobacillus actinomycetemcomitans J. Med. Microbiol., July 1, 2002; 51(7): 581 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Moron, P. Rueda, I. Casal, and C. Leclerc CD8{alpha}2 CD11b+ Dendritic Cells Present Exogenous Virus-like Particles to CD8+ T Cells and Subsequently Express CD8{alpha} and CD205 Molecules J. Exp. Med., May 20, 2002; 195(10): 1233 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Etchart, P.-O. Desmoulins, K. Chemin, C. Maliszewski, B. Dubois, F. Wild, and D. Kaiserlian Dendritic Cells Recruitment and In Vivo Priming of CD8+ CTL Induced by a Single Topical or Transepithelial Immunization Via the Buccal Mucosa with Measles Virus Nucleoprotein J. Immunol., July 1, 2001; 167(1): 384 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. E. A. Flesch, D. Stober, R. Schirmbeck, and J. Reimann Monocyte inflammatory protein-1{alpha} facilitates priming of CD8+ T cell responses to exogenous viral antigen Int. Immunol., September 1, 2000; 12(9): 1365 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Peppelenbosch, M. DeSmedt, G. Pynaert, S. J. H. van Deventer, and J. Grooten Macrophages Present Pinocytosed Exogenous Antigen Via MHC Class I Whereas Antigen Ingested by Receptor-Mediated Endocytosis Is Presented Via MHC Class II J. Immunol., August 15, 2000; 165(4): 1984 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Lipford, T. Sparwasser, S. Zimmermann, K. Heeg, and H. Wagner CpG-DNA-Mediated Transient Lymphadenopathy Is Associated with a State of Th1 Predisposition to Antigen-Driven Responses J. Immunol., August 1, 2000; 165(3): 1228 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schirmbeck, J. Wild, D. Stober, H. E. Blum, F. V. Chisari, M. Geissler, and J. Reimann Ongoing Murine T1 or T2 Immune Responses to the Hepatitis B Surface Antigen Are Excluded from the Liver that Expresses Transgene-Encoded Hepatitis B Surface Antigen J. Immunol., April 15, 2000; 164(8): 4235 - 4243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Campbell, T. Serwold, and N. Shastri Bacterial Proteins Can Be Processed by Macrophages in a Transporter Associated with Antigen Processing-Independent, Cysteine Protease-Dependent Manner for Presentation by MHC Class I Molecules J. Immunol., January 1, 2000; 164(1): 168 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wild, M. J. Grusby, R. Schirmbeck, and J. Reimann Priming MHC-I-Restricted Cytotoxic T Lymphocyte Responses to Exogenous Hepatitis B Surface Antigen Is CD4+ T Cell Dependent J. Immunol., August 15, 1999; 163(4): 1880 - 1887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schirmbeck, K. Melber, and J. Reimann Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen Int. Immunol., July 1, 1999; 11(7): 1093 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shimizu, L. G. Guidotti, P. Fowler, and F. V. Chisari Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice J. Immunol., November 1, 1998; 161(9): 4520 - 4529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Sigal, H. Reiser, and K. L. Rock The Role of B7-1 and B7-2 Costimulation for the Generation of CTL Responses In Vivo J. Immunol., September 15, 1998; 161(6): 2740 - 2745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-g. Chen, Y. Shi, J. D. Smith, D. Choi, J. D. Geiger, and J. J. Mule The Role of Tumor Necrosis Factor alpha in Modulating the Quantity of Peripheral Blood-Derived, Cytokine-Driven Human Dendritic Cells and Its Role in Enhancing the Quality of Dendritic Cell Function in Presenting Soluble Antigens to CD4+ T Cells In Vitro Blood, June 15, 1998; 91(12): 4652 - 4661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ludewig, S. Ehl, U. Karrer, B. Odermatt, H. Hengartner, and R. M. Zinkernagel Dendritic Cells Efficiently Induce Protective Antiviral Immunity J. Virol., May 1, 1998; 72(5): 3812 - 3818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rescigno, S. Citterio, C. Thery, M. Rittig, D. Medaglini, G. Pozzi, S. Amigorena, and P. Ricciardi-Castagnoli Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells PNAS, April 28, 1998; 95(9): 5229 - 5234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Butz and M. J. Bevan Differential Presentation of the Same MHC Class I Epitopes by Fibroblasts and Dendritic Cells J. Immunol., March 1, 1998; 160(5): 2139 - 2144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Krasteva, J. Kehren, F. Horand, H. Akiba, G. Choquet, M.-T. Ducluzeau, R. Tedone, J.-L. Garrigue, D. Kaiserlian, and J.-F. Nicolas Dual Role of Dendritic Cells in the Induction and Down-Regulation of Antigen-Specific Cutaneous Inflammation J. Immunol., February 1, 1998; 160(3): 1181 - 1190. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
